SubHero Banner
Text

Dexlansoprazole [Dexilant, Dexilant SoluTab] – Expanded indication

July 11, 2016 – Takeda announced the FDA approval of dexlansoprazole (Dexilant delayed-release capsules, Dexilant SoluTab orally disintegrating tablets) for the expansion of the current indications to include pediatric patients 12 to 17 years of age.

Download PDF